CRISPR Therapeutics And ViaCyte Collaborate To Create Universal Stem Cell Therapies For Diabetes
CRISPR Therapeutics and ViaCyte, Inc. have announced a collaboration focused on the discovery, development, and commercialization of gene-edited allogeneic stem cell therapies for the...
Cynata’s CYP-001 Stem Cell Therapy Meets Expectations In Phase 1 Graft-Versus-Host Disease Trial
Cynata Therapeutics Limited is an Australian clinical-stage stem cell and regenerative medicine company founded in 2003 that is developing a therapeutic stem cell platform...
IPS HEART Aims To Use Induced Pluripotent Stem Cells To Treat Heart Attack
IPS HEART is a privately-held biopharmaceutical company, founded in 2014, dedicated to addressing heart attack, heart failure and Duchenne cardiomyopathy via next generation cellular...
California Cryobank Stem Cell Services LLC Has Acquired Cord Blood America Inc
California Cryobank Stem Cell Services LLC ("FamilyCord"), has recently acquired Cord Blood America Inc. ("CBAI"), joining two of the industry's most respected stem cell...
Forever Labs Secures $2 Million For Stem Cell Banking
According to Health Services Research, approaching 80% of lifetime healthcare expenditures occur after age 40.
Forever Labs was founded in 2015 with offices in Ann...
ISBER And The Biobank Branch, China Medicinal Biotech Association (BBCMBA) Sign Affiliate Agreement
The International Society for Biological and Environmental Repositories (ISBER) seeks to address the harmonization of scientific, technical, legal, and ethical issues relevant to repositories...















